摘要
目的观察分析垂体后叶素联合普鲁卡因治疗肺结核咯血的疗效与安全性。方法选择在2015年1月—2017年1月收治入院的肺结核咯血患者80例作为研究对象。按照住院顺序,将其分成观察组与对照组,每组各40例。对照组给予垂体后叶素静滴,观察组在此基础上,联用普鲁卡因。对两组患者的临床总有效率和不良反应发生率进行对比分析。结果观察组患者的临床总有效率为92.5%(37/40),对照组患者的临床总有效率为75.0%(30/40),观察组高于对照组,差异具有统计学意义(P<0.05)。观察组不良反应发生率为17.5%(7/40),对照组不良反应发生率为37.5%(15/40),观察组不良反应发生率低于对照组,差异具有统计学意义(P<0.05)。结论垂体后叶素联合普鲁卡因应用于肺结核咯血的治疗,可明显提高治疗效果,减少不良反应的发生率。
Objective To explore the effects and security of pituitrin and procaine for pulmonary tuberculosis hemoptysis. Methods 80 cases of pulmonary tuberculosis hemoptysis patients from January 2015 to January 2017 were selected as the study objects. According to the order of hospitalization, they were divided into the observation group and the control group, 40 cases in each group. The control group received pituitrin intravenous drip. The observation group, on the basis of pituitrin intravenous drip, combined with procaine for treatment. The total effective rate and adverse reaction rate of the two groups were compared and analyzed. Results The total effective rate of the observation group was 92.5%（37/40）, the total effective rate of the control group was 75.0%（30/40）, the observation group was higher than that of the control group, the difference was statistically significant（P 〈 0.05）. The incidence of adverse reactions in the observation group was 17.5%（7/40）, the incidence of adverse reactions in the control group was 37.5%（15/40）, the incidence of adverse reactions in the observation group was lower than that in the control group, the difference was statistically significant（P 〈 0.05）. ConclusionPituitrin and procaine can improve the clinical effects and reduce the incidence of adverse reaction for pulmonary tuberculosis hemoptysis.
出处
《中国继续医学教育》
2017年第27期97-99,共3页
China Continuing Medical Education
关键词
垂体后叶素
普鲁卡因
肺结核咯血
疗效
安全性
pituitrin
procaine
pulmonary tuberculosis hemoptysis
effects
security
